Story perspectives

Brazil Can Make Lenacapavir for $75, Amid 18% Funding Cut

7/28/2026

Summary

Story summary

Officials at Brazil's 26th International AIDS Conference warned HIV financing fell 18% and patented lenacapavir costs $20,000 per patient.
The ABIA study found Brazil could produce lenacapavir for $75 per patient per year, below the patented price.
International HIV funding dropped $1.5 billion (18%) between 2024-2025 while development aid fell 23% in 2025.
HIV infections rose in three regions and 21 countries in 2025, totaling 1.2 million cases and 570,000 AIDS deaths.

1 of 1

Story summary

Officials at Brazil's 26th International AIDS Conference warned HIV financing fell 18% and patented lenacapavir costs $20,000 per patient.
The ABIA study found Brazil could produce lenacapavir for $75 per patient per year, below the patented price.
International HIV funding dropped $1.5 billion (18%) between 2024-2025 while development aid fell 23% in 2025.
HIV infections rose in three regions and 21 countries in 2025, totaling 1.2 million cases and 570,000 AIDS deaths.